Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024: PRMT5 Targeted Therapies Clinical Trials by Company, Indication & Phase [Yahoo! Finance]
Agios Pharmaceuticals, Inc. (AGIO)
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.agios.com/investor-overview
Company Research
Source: Yahoo! Finance
A comprehensive study, delineating the pioneering developments in the realm of PRMT5 (Protein Arginine Methyltransferase 5) targeted therapies, has been published. The report unravels the critical advances within the PRMT5 targeted therapy market, spotlighting over 25 clinical trials, segmented by company, indication, and phase. Within the study, readers will find in-depth analysis showcasing the current trends and developments, as well as a discerning clinical trials assessment within the US, UK, EU, China , and Canada . Further to this, the report synthesizes the global research trends for PRMT5 targeted therapies, accentuating the application of these therapies across varied indications. Significance of PRMT5 Targeted Therapies An exclusive dive into PRMT5's mechanism, revealing its pivotal role in sustaining cellular health and disease evolution. A detailed expedition into the prospective clinical trials reflecting the expanding interface of PRMT5 inhibitors and the thera
Show less
Read more
Impact Snapshot
Event Time:
AGIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGIO alerts
High impacting Agios Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AGIO
News
- Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024GlobeNewswire
- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Agios Publishes 2024 Environmental, Social and Governance (ESG) Report [Yahoo! Finance]Yahoo! Finance
- Agios Publishes 2024 Environmental, Social and Governance (ESG) ReportGlobeNewswire
- We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth [Yahoo! Finance]Yahoo! Finance
AGIO
Earnings
- 11/2/23 - Beat
AGIO
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- AGIO's page on the SEC website